Maniwa Y - Search Results

1

Effect of myasthenia gravis on the surgical outcomes of patients with thymoma.

Miura K, Doi T, Tanaka Y, Hokka D, Jimbo N, Itoh T, Maniwa Y. Miura K, et al. Among authors: maniwa y. Asian Cardiovasc Thorac Ann. 2022 Oct;30(8):924-930. doi: 10.1177/02184923221116679. Epub 2022 Jul 27. Asian Cardiovasc Thorac Ann. 2022. PMID: 35898168

2

Role of pleural lavage cytology before resection for primary lung carcinoma.

Okada M, Tsubota N, Yoshimura M, Miyamoto Y, Maniwa Y. Okada M, et al. Among authors: maniwa y. Ann Surg. 1999 Apr;229(4):579-84. doi: 10.1097/00000658-199904000-00019. Ann Surg. 1999. PMID: 10203093 Free PMC article.

3

Successful treatment of descending necrotizing mediastinitis.

Tanaka Y, Maniwa Y, Yoshimura M, Okita Y. Tanaka Y, et al. Among authors: maniwa y. Gen Thorac Cardiovasc Surg. 2007 Sep;55(9):366-9. doi: 10.1007/s11748-007-0147-1. Gen Thorac Cardiovasc Surg. 2007. PMID: 17937050

4

Double-layered collagen gel hemisphere for cell invasion assay: successful visualization and quantification of cell invasion activity.

Takata M, Maniwa Y, Doi T, Tanaka Y, Okada K, Nishio W, Ohbayashi C, Yoshimura M, Hayashi Y, Okita Y. Takata M, et al. Among authors: maniwa y. Cell Commun Adhes. 2007 Oct;14(4):157-67. doi: 10.1080/15419060701557859. Cell Commun Adhes. 2007. PMID: 17957531

5

The optimal timing to resect pulmonary metastasis.

Tanaka Y, Maniwa Y, Nishio W, Yoshimura M, Okita Y. Tanaka Y, et al. Among authors: maniwa y. Eur J Cardiothorac Surg. 2008 Jun;33(6):1135-8. doi: 10.1016/j.ejcts.2008.03.002. Epub 2008 Apr 8. Eur J Cardiothorac Surg. 2008. PMID: 18396056

6

DNA damage sensor protein hRad9, a novel molecular target for lung cancer treatment.

Yuki T, Maniwa Y, Doi T, Okada K, Nishio W, Hayashi Y, Okita Y. Yuki T, et al. Among authors: maniwa y. Oncol Rep. 2008 Nov;20(5):1047-52. Oncol Rep. 2008. PMID: 18949400

7

Expression and localization of FOXO1 in non-small cell lung cancer.

Maekawa T, Maniwa Y, Doi T, Nishio W, Yoshimura M, Ohbayashi C, Hayashi Y, Okita Y. Maekawa T, et al. Among authors: maniwa y. Oncol Rep. 2009 Jul;22(1):57-64. Oncol Rep. 2009. PMID: 19513505

8

Nonsynonymous single nucleotide polymorphisms in DNA damage repair pathways and lung cancer risk.

Tanaka Y, Maniwa Y, Bermudez VP, Doi T, Nishio W, Ohbayashi C, Okita Y, Hurwitz J, Hayashi Y, Yoshimura M. Tanaka Y, et al. Among authors: maniwa y. Cancer. 2010 Feb 15;116(4):896-902. doi: 10.1002/cncr.24850. Cancer. 2010. PMID: 20052722 Free article.

9

Overexpression of Necl-5 correlates with unfavorable prognosis in patients with lung adenocarcinoma.

Nakai R, Maniwa Y, Tanaka Y, Nishio W, Yoshimura M, Okita Y, Ohbayashi C, Satoh N, Ogita H, Takai Y, Hayashi Y. Nakai R, et al. Among authors: maniwa y. Cancer Sci. 2010 May;101(5):1326-30. doi: 10.1111/j.1349-7006.2010.01530.x. Epub 2010 Feb 11. Cancer Sci. 2010. PMID: 20331633 Free article.

10

MT1-MMP plays an important role in an invasive activity of malignant pleural mesothelioma cell.

Doi T, Maniwa Y, Tanaka Y, Tane S, Hashimoto S, Ohno Y, Nishio W, Nishimura Y, Ohbayashi C, Okita Y, Hayashi Y, Yoshimura M. Doi T, et al. Among authors: maniwa y. Exp Mol Pathol. 2011 Feb;90(1):91-6. doi: 10.1016/j.yexmp.2010.10.008. Epub 2010 Oct 19. Exp Mol Pathol. 2011. PMID: 20969861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page